Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Examination of the effect of Linagliptin versus placebo on diastolic function in patients
with type 2 diabetes mellitus and diastolic dysfunction as assessed by transthoracic
echocardiography.
Furthermore the effect on serum levels of NT-pro BNP as a biomarker of heart failure will be
investigated.